2-Picolinic acid structure
|
Common Name | 2-Picolinic acid | ||
---|---|---|---|---|
CAS Number | 98-98-6 | Molecular Weight | 123.109 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 292.5±13.0 °C at 760 mmHg | |
Molecular Formula | C6H5NO2 | Melting Point | 139-142 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 130.7±19.8 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of 2-Picolinic acidPCL 016 is a topical antiviral agent, which inhibits adenovirus replication in rabbit. |
Name | picolinic acid |
---|---|
Synonym | More Synonyms |
Description | PCL 016 is a topical antiviral agent, which inhibits adenovirus replication in rabbit. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vivo | Topical 1.5% PCL, 0.8% PCL, 0.369% PCL (pH7), 0.369% PCL (pH4) and 0.5% CDV are significantly more effective than the Control in reducing Ad Positive Cultures/Total (Days 1-14) and the Duration of Ad Shedding in the Ad5/NZW rabbit ocular model. Although not statistically significant, there appears to be a trend toward concentration-dependent efficacy of PCL 016 on the Duration of Ad Shedding. There is no apparent ocular toxicity associated with PCL 016 concentrations[1]. |
Animal Admin | Rabbits[1] 25 NZW rabbits are topically inoculated in both eyes, following corneal scarification, with 1.5 x 106 pfu/eye of Ad5. On day 1, the rabbits are divided into 6 topical treatment groups: I - 1.5% PCL 016 pH 7.0 (n=4); II - 0.8% PCL 016 pH 7.0 (n=4); III - 0.369% PCL 016 pH 7.0 (n=4); IV - 0.369% PCL 016 pH 4.0 (n=4); V - 0.5% Cidofovir (CDV) (n=4); VI - Control (saline) (n=5). PCL 016 and control rabbits are treated in both eyes 4 times daily for 7 days, while CDV rabbits are treated in both eyes twice daily for 7 days. All eyes are cultured for virus on days 0, 1, 3, 4, 5, 7, 9, 11, and 14[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 292.5±13.0 °C at 760 mmHg |
Melting Point | 139-142 °C(lit.) |
Molecular Formula | C6H5NO2 |
Molecular Weight | 123.109 |
Flash Point | 130.7±19.8 °C |
Exact Mass | 123.032028 |
PSA | 50.19000 |
LogP | -0.10 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.571 |
Storage condition | Store at RT. |
Water Solubility | 887 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H319 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn,Xi |
Risk Phrases | R22:Harmful if swallowed. R36:Irritating to the eyes. R36/37/38:Irritating to eyes, respiratory system and skin . |
Safety Phrases | S26-S36-S33-S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | TJ7344000 |
HS Code | 29333999 |
Precursor 8 | |
---|---|
DownStream 9 | |
HS Code | 29333999 |
---|
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Nature 457(7231) , 910-4, (2009) Multiple, complex molecular events characterize cancer development and progression. Deciphering the molecular networks that distinguish organ-confined disease from metastatic disease may lead to the i... |
|
Interaction of vanadium(IV) with human serum apo-transferrin.
J. Inorg. Biochem. 121 , 187-95, (2013) The interaction of V(IV)O-salts as well as of a few V(IV)O(carrier)n complexes with human serum transferrin (hTF) is studied focusing on the determination of the nature and stoichiometry of the bindin... |
|
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
J. Med. Chem. 54 , 591-602, (2011) Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors. When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compounds produced... |
2-pyridinecarboxylic acid |
Picolinic acid |
pyridine-2-carboxylic acid |
acidepicolique |
EINECS 202-719-7 |
2-Carboxypyridine |
MFCD00006293 |
2-acid pyridine |
2-Picolinic acid |
Sorafenib Impurity 18 |
PCL 016 |